Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ohm, formerly known as OhmBody, is a bioelectronic medicine company focused on developing wearable therapeutic devices for chronic pain management. Founded by former Apple and Tesla engineers, the company leverages advanced electrical stimulation technology to provide non-invasive, drug-free relief for musculoskeletal conditions. The Ohm platform combines sleek hardware with intelligent software to deliver personalized bioelectronic therapy directly to users. By targeting specific neural pathways, the device aims to disrupt pain signals and improve quality of life for individuals suffering from persistent pain. The company is backed by prominent investors including Khosla Ventures and Y Combinator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OhmBody.